Lv3
396 积分 2023-03-11 加入
Clinicopathologic features and prognoses of different histologic types of triple-negative breast cancer: A large population-based analysis
1个月前
已完结
Integration of whole-genome sequencing and functional screening identifies a prognostic signature for lung metastasis in triple-negative breast cancer
1个月前
已完结
TNBC’s compass: Navigating prognosis with a cellular map
1个月前
已完结
Spatial determinants of antibody-drug conjugate SHR-A1811 efficacy in neoadjuvant treatment for HER2-positive breast cancer
1个月前
已完结
Letter re: Efficacy and safety of neoadjuvant SHR-A1811 with or without pyrotinib in women with locally advanced or early HER2-positive breast cancer: a randomized, open-label, phase II trial
2个月前
已完结
Trastuzumab Deruxtecan plus Pertuzumab for HER2-Positive Metastatic Breast Cancer
2个月前
已完结
Molecular and clinical insights of trastuzumab deruxtecan efficacy in advanced breast cancer
2个月前
已完结
Small airway fibrosis in COPD
2个月前
已完结
p95HER2, a truncated form of the HER2 oncoprotein, drives an immunosuppressive program in HER2+ breast cancer that limits trastuzumab deruxtecan efficacy
2个月前
已完结
Trastuzumab Deruxtecan after Endocrine Therapy in Metastatic Breast Cancer
2个月前
已完结
皖公网安备34019202002308
